Genuine Latisse - $49 each when you buy 2

Latisse Faces Patent Challenge

July 13, 2010 · Posted in Daily Health News · Comment 

The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version. (Source: WSJ.com: Health)

More here:
Latisse Faces Patent Challenge

Latisse Faces Patent Challenge

July 13, 2010 · Posted in Daily Health News · Comment 

The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version.

Read the original post:
Latisse Faces Patent Challenge

Latisse Faces Patent Challenge

July 13, 2010 · Posted in Daily Health News · Comment 

The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version.

See the original post:
Latisse Faces Patent Challenge